1721 (1721) Fair Value & Analysis

Industrials · Market cap HK$140M

1 1721 1721 · HK

PriceHK$0.1400

Fair ValueHK$0.0200

Upside-85.7%

Quality43/100

Watch 1721 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.0200 – HK$0.0200

Fair value as of: Jul 2, 2026

From 3 valuation models · updated today

Price vs Fair Value (12 months)

12‑month range HK$0.1400 – HK$0.6500 · the HK$0.1400 price screens above the HK$0.0200 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1721 (1721) currently trades at HK$0.1400, while our model-based Fair Value estimate is HK$0.0200 — implying the stock looks roughly 85.7% overvalued today. We read business quality at 43/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1721 generated revenue of HK$15.8M at a net margin of -44.1%. Revenue grew 13.3% year over year. It earns a return on equity of -22.8%. The balance sheet holds a net cash position of HK$20.7M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$15.8M

Revenue growth (YoY) +13.3%

Net margin -44.1%

Return on equity -22.8%

Free cash flow −HK$3.0M FY2024

Operating margin -6.9%

More key figures

EPS growth (YoY) +2,000%

Net cash HK$20.7M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

1721 reported revenue of HK$14.9M in FY2024 versus HK$10.3M in FY2020, a compound +9.5%/yr. Reported net income was −HK$3.4M in FY2024.

Revenue +9.5%/yr

FY20 HK$10.3M

FY21 HK$16.1M

FY22 HK$23.3M

FY23 HK$16.1M

FY24 HK$14.9M

Net income

FY20 −HK$2.6M

FY21 −HK$3.1M

FY22 HK$2.1M

FY23 −HK$4.9M

FY24 −HK$3.4M

Is 1721 fairly valued? → Check now

Similar stocks

6 more Metal Fabrication stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
ATI Inc ATI	$204.09	$36.39	-82%
Carpenter Technology Corporation CRS	$492.62	$82.57	-83%
Mueller Industries, Inc MLI	$132.44	$125.26	-5%
Aurubis AG NDA	€216.20	€116.94	-46%
Commercial Metals Company CMC	$73.57	$28.97	-61%
China International Marine Containers (Group) Co 000039	¥8.98	¥12.75	+42%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1721 (1721) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0200 versus a price of HK$0.1400 — about −86% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1721?

Our model-based fair value for 1721 is HK$0.0200 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1400.

What is the quality score of 1721?

1721 has a Quality Score of 43/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1721 (1721)?

1721 reported trailing-twelve-month revenue of about HK$15.8M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1721?

The net profit margin of 1721 is about -44.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.